Stemnovate

About:

Drug Screening and Safety Testing Platforms

Top Investors: Innovate UK, O2h Ventures, Cambridge Angels group

Description:

Stemnovate is a unique, innovative drug development platforms enable the right patients to be targeted with the right treatments, at the right time.

Total Funding Amount:

1.83M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Babraham, Cambridgeshire, United Kingdom

Founded Date:

2017-01-01

Contact Email:

info(AT)stemnovate.co.uk

Founders:

Adrian Fisher, David Hay, Ruchi Sharma

Number of Employees:

11-50

Last Funding Date:

2022-08-04

IPO Status:

Private

Industries: